In addition, as depletion of NUAK1 greatly inhibited the migration and invasion in vitro and metastasis in vivo, indicating targeting NUAK1 is a promising therapeutic strategy for metastatic ESCC. The gene discussed is NUAK1; the disease is esophageal squamous cell carcinoma.